Raaven Therapeutics AB

Active
559373-4063Limited company (AB)Registered 2022FLYINGE

Key figures

43 990 679 kr+222,2%
Revenue 2025
+175,8%
Average annual growth 2022–2025
020 m40 m60 m2022202320242025

Key figures

2025

Summary: Raaven Therapeutics AB

What kind of company is it?

Raaven Therapeutics AB (org. no. 559373-4063) is a limited company (AB). The company was registered in 2022 and has existed for 4 years. Registered seat: Flyinge. Industry according to Statistics Sweden: research and experimental development on biotechnology (SNI 72101).

How is the company doing financially?

Net sales in financial year 2025 were 43 990 679 kr, up 222 % on the previous year (13 652 000 kr). From 2022 to 2025, net sales grew by an average of 176 % per year. This is the highest net sales among the reported years (2022–2025). Net profit for 2025 was 19 453 249 kr (44,2 % of net sales). The company was profitable in all 4 reported financial years. Employees in financial year 2025: 6. Net sales per employee were 7 331 780 kr. At the end of financial year 2025, total assets were 35 441 294 kr and equity 20 251 973 kr (equity ratio 57,1 %). The annual report for 2025 proposes a dividend of 10 000 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 4 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 10 000 000 kr.

History
202510 000 000 kr
20242 000 000 kr
Summary of annual reports2022–2025
2022202320242025
Sales revenue2 097 0004 488 00013 652 00043 990 679
Profit for the reporting year146 010305 5182 322 19719 453 249
Retained earnings of previous periods————
Total assets996 6741 443 3664 614 44735 441 294
Total liabilities825 664966 8381 815 72315 189 321
Total equity171 010476 5282 798 72420 251 973
Employees1266
Proposed dividend——2 000 00010 000 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.